SEATTLE & LONDON--(BUSINESS WIRE)--Targeted Genetics Corporation (TGEN.PK) announced today that it will webcast its annual shareholder meeting on Friday, February 18, 2011 at noon ET/9:00 a.m. PT. Jeremy Curnock Cook, Targeted Genetics’ Chairman, will conduct the formal business of the meeting and Edward Cappabianca, the Company’s chief executive officer, will provide a business update.
You may access the live webcast, which will include a slide presentation, by going to the investor relations section of the Targeted Genetics website, found at www.targen.com or via telephone at US toll free 877-795-3647, PIN code 5291705 or toll free in the UK at 0808 101 7162, PIN code 5291705.
Please go to the web site at least 15 minutes early to register, download and install any necessary audio software. A replay will be available for 30 days on the Targeted Genetics investor relations home page after the meeting is completed.
About Targeted Genetics Corporation
Through the recent acquisition of Biocontrol Ltd., Targeted Genetics has repositioned is business to focus on developing anti-infective therapeutics to treat highly antibiotic-resistant bacterial infections. The science behind our products in development is centered around bacteriophages which are capable of infecting and destroying drug-resistant bacteria and in this context can be selected and used to produce novel therapeutic products. Antibiotic-resistant bacteria are a significant and growing healthcare concern, and there is a substantial clinical and commercial opportunity for novel approaches that can treat bacterial infections that do not respond to current therapies.